In line with the results obtained by DNA methylation chip, the methylation rate of MBP and HLA-DQB2 in CD4+ T cells was significantly lower in IgG4-RD patients than in HCs (Fig. 2C). This evidence concerns the gene HLA-DQB2 and immunoglobulin G4-related sclerosing disease.